Unknown

Dataset Information

0

Early myeloid-derived suppressor cells (HLA-DR-/lowCD33+CD16-) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCT.


ABSTRACT: INTRODUCTION:Myeloid-derived suppressor cells (MDSCs) are proposed to control graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the definition of human MDSCs has not yet reached consensus, and the mechanism of MDSCs to control GVHD remains unclear. METHODS:Immature myeloid cells (HLA-DR-/lowCD33+CD16-) were tested before and after granulocyte colony-stimulating factor (G-CSF) administration in healthy donor and isolated for suppression assays and co-culture with T cells in vitro. Isolated cells were infused in humanized mice for a xenogeneic model of acute GVHD. One hundred allo-HSCT recipients were enrolled prospectively to assess the role of HLA-DR-/lowCD33+CD16- cells in grafts on the occurrence of acute GVHD. RESULTS:In the present study, G-CSF mobilized HLA-DR-/lowCD33+CD16- cells with immunosuppressive properties in donor peripheral blood. These cells contained more interleukin-10+ and transforming growth factor-beta (TGF-?)+ cells after G-CSF administration and inhibited the proliferation of autologous donor T cells in a TGF-?-dependent manner. Meanwhile, these immature myeloid cells promoted regulatory T cell expansion and induced Th2 differentiation. Importantly, these cells prevented acute GVHD in a humanized mouse model. Moreover, clinical cohort results showed that the number of HLA-DR-/lowCD33+CD16- cells in the donor graft was the only independent risk factor inversely correlated with the incidence of grade II-IV acute GVHD in the recipients (HR 0.388, 95% CI 0.158-0.954, p?=?0.039). CONCLUSION:HLA-DR-/lowCD33+CD16- cells represent functional MDSCs that may control acute GVHD in allo-HSCT.

SUBMITTER: Wang K 

PROVIDER: S-EPMC6423891 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Early myeloid-derived suppressor cells (HLA-DR<sup>-</sup>/<sup>low</sup>CD33<sup>+</sup>CD16<sup>-</sup>) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCT.

Wang Ke K   Lv Meng M   Chang Ying-Jun YJ   Zhao Xiang-Yu XY   Zhao Xiao-Su XS   Zhang Yuan-Yuan YY   Sun Yu-Qian YQ   Wang Zhi-Dong ZD   Suo Pan P   Zhou Yang Y   Liu Dan D   Zhai Shu-Zhen SZ   Hong Yan Y   Wang Yu Y   Zhang Xiao-Hui XH   Xu Lan-Ping LP   Liu Kai-Yan KY   Huang Xiao-Jun XJ  

Journal of hematology & oncology 20190318 1


<h4>Introduction</h4>Myeloid-derived suppressor cells (MDSCs) are proposed to control graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the definition of human MDSCs has not yet reached consensus, and the mechanism of MDSCs to control GVHD remains unclear.<h4>Methods</h4>Immature myeloid cells (HLA-DR<sup>-/low</sup>CD33<sup>+</sup>CD16<sup>-</sup>) were tested before and after granulocyte colony-stimulating factor (G-CSF) administration  ...[more]

Similar Datasets

| S-EPMC8024657 | biostudies-literature
| S-EPMC2945885 | biostudies-literature
| S-EPMC9869507 | biostudies-literature
| S-EPMC7726260 | biostudies-literature
| S-EPMC9804750 | biostudies-literature
| S-EPMC4742622 | biostudies-literature
| S-EPMC10516146 | biostudies-literature
| S-EPMC8342225 | biostudies-literature
| S-EPMC4833737 | biostudies-literature